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Background:
 
 Primary systemic amyloidosis (AL) is a severe plasma cell
disorder characterized by amyloid fibrils extracellular deposition in different
organs. Myocardial involvement is frequent and has major impact on prog-
nosis. Echocardiography (TTE) is the most common test performed when car-
diac involvement is suspected. We hypothesized that a simple measurement of
left atrium enlargement (LA) by TTE may provide an important risk marker
for this disease.
 
Methods and results: 
 
Between 1997 and 2010, 109 patients were diag-
nosed with systemic AL and had first TTE within 21 days. Patients were
mainly treated with conventional chemotherapy (M-Dex) with new agents for
refractory or relapsing patients We retrospectively collected demographic
baseline characteristics along with biological and echo data of these patients.
Mean age was 63±11 years; 58% were male; 24% had hypertension. Mean left
ventricular ejection fraction and mean LV wall thickness were respectively
62±13% and 13±3 mm. Mean follow up time was 2.42±2 years. None had sig-
nificant valvular heart disease. LA enlargement was defined by M mode as >
40 mm in male and > 36 mm in female. Patients with enlarged LA were more
often male, slightly older (p=0.05) and with slightly more hypertension
(p=0.07) but had significantly lower ejection fraction and more hypertrophied
LV walls (All P< 0.05). At 5 years, survival rate was markedly reduced in
patients with enlarged LA vs. those with normal LA: 31±10% vs.75±7%
(P=0.001). By multivariate analysis, after adjusting for age, gender, LVEF,
LV wall thickness and presence of hypertension, LA enlargement remained an
independent predictor of overall mortality at five years (P=0.03).
 
Conclusion:
 
 In patients with systemic AL amyloidosis, LA enlargement, a
surrogate marker of diastolic dysfunction and elevated LV filling pressure, is
a powerful independent predictor of long-term mortality. Therefore LA
enlargement may help to enhance risk stratification in patients presenting with
this disease.
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2D and 3D diastolic strain rate by speckle tracking for assessing left
ventricular end diastolic pressure
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Luc Dubois-Rande, Pascal Lim
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Purpose:
 
 The aim of the study was to compare the accuracy of longitudinal
diastolic velocity and strain rate (SR) obtained by tissue Doppler imaging
(TDI), 2D and 3D speckle tracking in assessing left ventricular end diastolic
pressure (LVEDP)
 
Methods: 
 
LVEDP measurements were performed in 40 consecutive patients
referred for coronary angiogram (mean age= 60 ± 15 years, mean EF= 41 ±
14%). A comprehensive transthoracic echocardiography (Artida, Toshiba) study
was performed immediately after LVEDP measurement. Echocardiography data
acquired included mitral early diastolic velocity (E) by conventional pulsed
Doppler, early diastolic mitral annulus velocity by TDI (E’), and high frame rate
2 and 3D apical views. Global longitudinal SR by 2D (2DE
 
GSR
 
) and 3D
(3DE
 
GSR
 
) were assessed using longitudinal strain curves from speckle tracking
analysis. LV filling pressure estimated using echocardiography data (E/E’, E/
2DE
 
GSR
 
, E/3DE
 
GSR
 
) were correlated to invasive LVEDP measurements.
 
Result:
 
 On the whole, LVEDP averaged 13mmHg (5 to 32,) and best cor-
related with LV filling pressure assessed by 2D speckle tracking (r
 
2
 
=0.65,
p<0.0001). In contrast, conventional E/E’ by TDI and E/3DE
 
GSR
 
 poorly corre-
lated with LVEDP (see Figure).
 
Conclusions:
 
 Longitudinal diastolic strain rate by 2D and not 3D speckle
tracking appears superior to conventional E/E’ by TDI for assessing LV filling
pressure.
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“New” echocardiographic isovolumetric parameters combined with
standard parameters for the assessment of left ventricular filling pres-
sures
Aurélia Tho, Pamela Moceri, David Bertora, Didier Scarlatti, Jean-Pierre
Camous, Pierre Gibelin
CHU Nice – Hôpital Pasteur, Cardiologie, Nice, France
Left ventricular filling pressures’ evaluation is still challenging. The ratio
of the transmitral and myocardial early diastolic velocities (E/E') can be used
to estimate LV filling pressures (LVFP), but between 8 and 15 it remains
unclear. Additionally, the time difference between the onset of E and E'
(
 
Δ
 
 (RE-E’)), the time difference between onset of mitral inflow and onset of
early diastolic mitral annulus velocity (
 
Δ
 
 (IVRT-IVRT’)) and the mitral early
diastolic velocity (E)/Strain rate ratio during the isovolumetric relaxation
period also correlate to LVFP. The aim of this study was to evaluate the incre-
mental value of those indices to evaluate LVFP (as measured by left ventric-
ular end diastolic pressure (LVEDP)) in a heterogeneous group of patients
during a simultaneous invasive procedure.
Simultaneous cardiac catheterization, BNP dosage and doppler echocardio-
graphy were performed in 30 patients. LVEDP was elevated (>16 mm Hg) in
14 patients (46,7%). The 3 previously described “new” parameters are signifi-
cantly correlated to LVEDP, but particularly highly significant correlation was
found between 
 
Δ
 
(IVRT-IVRT’) and LVEDP (r = -0,74, p < 0,005). ROC
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Survival Curve in patients with systemic (AL)
amyloidosis according to LA size
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